Literature DB >> 21621027

Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects.

Yash M Kolambkar1, Joel D Boerckel, Kenneth M Dupont, Mehmet Bajin, Nathaniel Huebsch, David J Mooney, Dietmar W Hutmacher, Robert E Guldberg.   

Abstract

Osteogenic growth factors that promote endogenous repair mechanisms hold considerable potential for repairing challenging bone defects. The local delivery of one such growth factor, bone morphogenetic protein (BMP), has been successfully translated to clinical practice for spinal fusion and bone fractures. However, improvements are needed in the spatial and temporal control of BMP delivery to avoid the currently used supraphysiologic doses and the concomitant adverse effects. We have recently introduced a hybrid protein delivery system comprised of two parts: a perforated nanofibrous mesh that spatially confines the defect region and a functionalized alginate hydrogel that provides temporal growth factor release kinetics. Using this unique spatiotemporal delivery system, we previously demonstrated BMP-mediated functional restoration of challenging 8mm femoral defects in a rat model. In this study, we compared the efficacy of the hybrid system in repairing segmental bone defects to that of the current clinical standard, collagen sponge, at the same dose of recombinant human BMP-2. In addition, we investigated the specific role of the nanofibrous mesh tube on bone regeneration. Our results indicate that the hybrid delivery system significantly increased bone regeneration and improved biomechanical function compared to collagen sponge delivery. Furthermore, we observed that presence of the nanofiber mesh tube was essential to promote maximal mineralized matrix synthesis, prevent extra-anatomical mineralization, and guide an integrated pattern of bone formation. Together, these results suggest that spatiotemporal strategies for osteogenic protein delivery may enhance clinical outcomes by improving localized protein retention.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21621027      PMCID: PMC3143222          DOI: 10.1016/j.bone.2011.05.010

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  48 in total

Review 1.  Bone morphogenetic proteins: an update on basic biology and clinical relevance.

Authors:  J M Schmitt; K Hwang; S R Winn; J O Hollinger
Journal:  J Orthop Res       Date:  1999-03       Impact factor: 3.494

2.  Regeneration of segmental diaphyseal defects in sheep tibiae using resorbable polymeric membranes: a preliminary study.

Authors:  Z Gugala; S Gogolewski
Journal:  J Orthop Trauma       Date:  1999 Mar-Apr       Impact factor: 2.512

3.  Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies.

Authors:  Marc F Swiontkowski; Hannu T Aro; Simon Donell; John L Esterhai; James Goulet; Alan Jones; Philip J Kregor; Lars Nordsletten; Guy Paiement; Amratlal Patel
Journal:  J Bone Joint Surg Am       Date:  2006-06       Impact factor: 5.284

Review 4.  Clinical applications of BMPs.

Authors:  Pietro De Biase; Rodolfo Capanna
Journal:  Injury       Date:  2005-11       Impact factor: 2.586

Review 5.  Bone substitutes: an update.

Authors:  Peter V Giannoudis; Haralambos Dinopoulos; Eleftherios Tsiridis
Journal:  Injury       Date:  2005-11       Impact factor: 2.586

6.  Allograft bone decreases in strength in vivo over time.

Authors:  Donna L Wheeler; William F Enneking
Journal:  Clin Orthop Relat Res       Date:  2005-06       Impact factor: 4.176

Review 7.  Role of morphogenetic proteins in skeletal tissue engineering and regeneration.

Authors:  A H Reddi
Journal:  Nat Biotechnol       Date:  1998-03       Impact factor: 54.908

Review 8.  Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair.

Authors:  J M Wozney; V Rosen
Journal:  Clin Orthop Relat Res       Date:  1998-01       Impact factor: 4.176

9.  Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.

Authors:  Lisa B E Shields; George H Raque; Steven D Glassman; Mitchell Campbell; Todd Vitaz; John Harpring; Christopher B Shields
Journal:  Spine (Phila Pa 1976)       Date:  2006-03-01       Impact factor: 3.468

10.  rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics.

Authors:  H Uludag; W Friess; D Williams; T Porter; G Timony; D D'Augusta; C Blake; R Palmer; B Biron; J Wozney
Journal:  Ann N Y Acad Sci       Date:  1999-06-18       Impact factor: 5.691

View more
  52 in total

1.  Mechanical regulation of vascular growth and tissue regeneration in vivo.

Authors:  Joel D Boerckel; Brent A Uhrig; Nick J Willett; Nathaniel Huebsch; Robert E Guldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

2.  Recapitulating bone development through engineered mesenchymal condensations and mechanical cues for tissue regeneration.

Authors:  Anna M McDermott; Samuel Herberg; Devon E Mason; Joseph M Collins; Hope B Pearson; James H Dawahare; Rui Tang; Amit N Patwa; Mark W Grinstaff; Daniel J Kelly; Eben Alsberg; Joel D Boerckel
Journal:  Sci Transl Med       Date:  2019-06-05       Impact factor: 17.956

3.  BMP-2 delivery strategy modulates local bone regeneration and systemic immune responses to complex extremity trauma.

Authors:  Casey E Vantucci; Laxminarayanan Krishan; Albert Cheng; Ayanna Prather; Krishnendu Roy; Robert E Guldberg
Journal:  Biomater Sci       Date:  2021-03-10       Impact factor: 6.843

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

Review 5.  Advanced BMP gene therapies for temporal and spatial control of bone regeneration.

Authors:  C G Wilson; F M Martín-Saavedra; N Vilaboa; R T Franceschi
Journal:  J Dent Res       Date:  2013-03-28       Impact factor: 6.116

Review 6.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

7.  HYDROGEL-BASED NANOCOMPOSITES OF THERAPEUTIC PROTEINS FOR TISSUE REPAIR.

Authors:  Suwei Zhu; Tatiana Segura
Journal:  Curr Opin Chem Eng       Date:  2014-05-01       Impact factor: 5.163

8.  Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds.

Authors:  Sungsoo S Lee; Brian J Huang; Stuart R Kaltz; Shantanu Sur; Christina J Newcomb; Stuart R Stock; Ramille N Shah; Samuel I Stupp
Journal:  Biomaterials       Date:  2012-10-23       Impact factor: 12.479

9.  Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.

Authors:  Laxminarayanan Krishnan; Lauren B Priddy; Camden Esancy; Mon-Tzu Alice Li; Hazel Y Stevens; Xi Jiang; Lisa Tran; David W Rowe; Robert E Guldberg
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

10.  Delivery vehicle effects on bone regeneration and heterotopic ossification induced by high dose BMP-2.

Authors:  Laxminarayanan Krishnan; Lauren B Priddy; Camden Esancy; Brett S Klosterhoff; Hazel Y Stevens; Lisa Tran; Robert E Guldberg
Journal:  Acta Biomater       Date:  2016-12-08       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.